top of page
Untitled design (5).png

Platform and Pipeline

Advancing Preclinical Research in Lymphatic Biology

LYMPHOGENiX is developing a lymphangiogenic research platform informed by more than 15 years of foundational investigation into lymphatic biology.
The platform integrates cellular biology, immunology, and regenerative science to explore how modulation of lymphatic pathways may be relevant across selected biological contexts.

Current activities remain at a preclinical stage.

statusBrand.webp

A Focused and Evidence-Driven Development Strategy

The company’s lead research focus is human infertility, where implantation biology remains incompletely understood. While embryo quality has improved through technological advances, uterine microenvironment factors may contribute to implantation variability in certain cases. LYMPHOGENiX is investigating whether lymphatic modulation may be associated with biological parameters relevant to this context.

Additional exploratory programmes are being assessed in parallel, based on the broader hypothesis that lymphatic function may influence tissue homeostasis and inflammatory signalling. These programmes remain at early investigative stages.

01

Human Infertility (Preclinical Stage)

The lead programme investigates lymphatic modulation within the uterine microenvironment in controlled experimental models.

Current objectives include:

  • Generating and expanding preclinical data in murine models

  • Planning large-animal translational studies to evaluate feasibility, dosing parameters, and biological response

  • Refining mechanistic understanding of lymphatic involvement in implantation-related pathways

 

Large-animal studies are intended to support translational planning and study design considerations. They do not constitute clinical validation.

Human clinical trials have not yet commenced. Any progression toward First-in-Human evaluation will depend on additional preclinical evidence and regulatory review.

02

Fibrotic Conditions

Research is investigating whether modulation of lymphatic pathways may be associated with inflammatory signalling and tissue remodelling processes observed in fibrotic contexts.

03

Skin Ageing

Early-stage investigations are examining potential associations between lymphatic biology and tissue structure, immune balance, and age-related microenvironmental changes in experimental models.

04

Metabolic Disorders

Preliminary studies are exploring possible links between lymphatic regulation, inflammation, and metabolic processes.

None of these programmes has advanced to clinical evaluation.

Summary

The LYMPHOGENiX platform supports structured preclinical research into lymphatic biology and its potential relevance across selected biological indications. All programmes described remain investigational. Clinical efficacy and safety in humans have not been established.

View Investor Overview
bottom of page